GFI1Bmutation causes autosomal dominant gray platelet syndrome
Author Information: The Canadian Pharmacogenomic Network for Drug Safety (CPNDS), Center for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, V5Z4H4, Canada
|Checking for direct PDF access through Ovid|
A dominant-negative GFI1B mutation in the gray platelet syndrome.
Monteferrari, et al. (2014)
N Engl J Med; 370(3):245–253.